Answers are grounded in this paper and cite their sources.
PURPOSE OF REVIEW: In this review, we will summarize recent developments in our understanding of the role of protease-activated receptor 4 (PAR4) on hemostasis and thrombosis. RECENT FINDINGS: Thrombin-dependent cleavage of platelet thrombin receptors leads to platelet activation and aggregation. All platelets express the thrombin receptor, PAR4. In addition to PAR4, human platelets express the other functional thrombin receptors, PAR1. Due to their specific structure, PAR1 exhibits high affinity and PAR4 a low affinity for thrombin. Because of its sensitivity to low thrombin concentrations, it is thought that in the human system, platelet PAR1 is mostly involved in hemostasis. In thrombotic processes, high thrombin concentration are generated and, therefore, PAR4 was identified as a potential antithrombotic target. To better understand the role of PAR4 in vivo, novel mouse models were developed expressing a hyperreactive or hyporeactive PAR4 variant. Moreover, mice expressing a conditional PAR4 gene allows now the detailed cell-specific contribution of PAR4. Indeed, the new tools already verified platelet PAR4's contribution to arterial and venous thrombosis as well as ischemic stroke. SUMMARY: In this review, we will summarize and discuss recent advances in our understanding of PAR4's role as platelet receptor. The novel tools will advance the development of new effective antithrombotic strategies by targeting PAR4.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: